Pharmesis International Ltd (PHAR)

Singapore
0.215
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.25/0.32
  • Day's Range:
    0.215 - 0.215

PHAR Overview

Prev. Close
0.215
Day's Range
0.215 - 0.215
Revenue
9.66M
Open
0.215
52 wk Range
0.178 - 0.45
EPS
-0.05
Volume
0
Market Cap
4.95M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
1,100
P/E Ratio
-
Beta
0.44
1-Year Change
30.3%
Shares Outstanding
23,000,000
Next Earnings Date
May 18, 2021
What is your sentiment on Pharmesis International Ltd?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsBuySellSellStrong SellSell
SummaryNeutralSellSellStrong SellStrong Sell

Pharmesis International Ltd Company Profile

Pharmesis International Ltd Company Profile

Employees
0
Market
Singapore

Pharmesis International Ltd. is a Singapore-based investment holding company. The Company is a pharmaceutical company engaged in the manufacturing of pharmaceutical products, including western medicine in the form of tablets and granules, among others, and traditional Chinese medicine (TCM) formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates in three segments: Western drugs, which refers mainly to chemically formulated drugs marketed under the Kinna brand; TCM formulated drugs, which includes TCM marketed under the Longlife brand, and Distribution, which includes agency products and internally manufactured products marketed through the distribution arm. Its main products are ATT, Gulin Gansu and Er Ding granules. Its subsidiary, Chengdu Kinna Pharmaceutical Co., Ltd, is engaged in the development, manufacture, packaging and sale of western medicines and health tonic products.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.